• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    urban-gro, Inc. Announces Inclusion in Russell 2000® Index and Appoints Seasoned Executives to Board of Directors

    6/14/21 9:05:00 AM ET
    $CRON
    $UGRO
    Medicinal Chemicals and Botanical Products
    Health Care
    Industrial Specialties
    Consumer Discretionary
    Get the next $CRON alert in real time by email

    - Company added to the Russell 2000® Index as part of the annual reconstitution of the Russell stock indexes

    - Appointment of Anita Britt and David Hsu to Board of Directors bolsters international operational and financial expertise with a successful track record of driving growth and profitability

    LAFAYETTE, Colo., June 14, 2021 (GLOBE NEWSWIRE) -- urban-gro, Inc. (NASDAQ:UGRO) ("urban-gro" or the "Company"), a leading global horticulture company that engineers and designs commercial Controlled Environment Agriculture ("CEA") facilities and integrates complex environmental equipment systems, today announced that it has been selected to be added to the Russell 2000® Index effective June 25, 2021, after the close of the U.S. equity markets. The Russell 2000® Index measures the performance of the small-cap segment of the US equity market. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies.

    Bradley Nattrass, Chief Executive Officer and Chairman of urban-gro commented "Our team has continued to drive execution and growth on multiple fronts. We are pleased to have been selected for inclusion into the Russell 2000® Index and plan to leverage this beneficial exposure and our continued execution to drive additional shareholder value."

    In addition, urban-gro also announced that effective June 9, 2021, Anita Britt, CPA, and David Hsu have been appointed to the Company's Board of Directors and Lance Galey has resigned from the Board.

    "As we thank Lance for his great insight and guidance over the last three years, garnering the attention and expertise of both Anita and David brings a great deal of value to our Company. They collectively bring operational and financial expertise, a successful track record of execution, and a deep knowledge of the CEA space. We look forward to leveraging their expertise as we continue to unlock the full potential of urban-gro" concluded Mr. Nattrass.

    Ms. Britt is a well-established financial executive with more than 30 years of global business experience leading all aspects of corporate financial management focused on driving profitability and financial returns. She joins the urban-gro Board of Directors, having most recently served as the Chief Financial Officer of Perry Ellis International. During her tenure at Perry Ellis, Ms. Britt was responsible for key business strategies to drive return on invested capital as well as capital markets transactions. Ms. Britt currently serves on the Board of Directors of Smith & Wesson Brands Inc., where she chairs the Audit Committee and is a member of the Compensation Committee. She also serves on the Board of Delta Apparel, Inc. and is a member of both the Audit and Governance Committees. Ms. Britt is a National Association of Corporate Directors (NACD) Board Leadership Fellow and holds an active license with the American Institute of Certified Public Accountants. At urban-gro, Ms. Britt will serve as the Chair of the Audit Committee and as a member of both the Compensation and Governance Committees.

    Mr. Hsu, a recognized leader with extensive experience in both corporate strategy and operational execution, most recently served as the founding Chief Operating Officer of The Cronos Group (NASDAQ:CRON), a globally diversified and vertically integrated cannabis company with a presence across five continents. In addition to overseeing all operations and expansion, Mr. Hsu also managed the design and construction of Cronos's purpose-built CEA and manufacturing facilities, some of the most advanced in the world. He brings extensive high-performance controlled environmental agriculture (CEA) expertise to urban-gro. Mr. Hsu will serve as a member of both the Audit and Compensation committees.

    About urban-gro, Inc.

    urban-gro, Inc. (NASDAQ:UGRO) is a global engineering and design services company focused on the commercial horticulture market. With experience in hundreds of Controlled Environment Agriculture (CEA) facilities spanning millions of square feet, we engineer, design and integrate complex environmental equipment systems into high-performance facilities. 

    Once operational, urban-gro's gro-care® Managed Services Platform leverages the company's expertise to reduce downtime, provide continuity, and drive facility optimization. Operating as a crop-agnostic solutions provider in both food and cannabis CEA sectors, our crop-focused end-to-end approach provides a single point of accountability across all aspects of growing operations. 

    Visit urban-gro.com to discover how we help cultivators gro plants and gro profits.

    Safe Harbor Statement

    This press release contains forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. When used in this release, terms such as "believes," "estimates," "should," "could," "would," "plans," "expects," "intends," "anticipates," "may," "forecasts," "projects" and similar expressions and variations as they relate to the Company, or its management are intended to identify forward-looking statements. Such forward-looking statements are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the demand for our services and products, our ability to manage the adverse effect brought on by the COVID-19 pandemic, our ability to execute on our strategic plans, our ability to achieve positive cash flows or profitability, our ability to achieve and maintain cost savings, the sufficiency of our liquidity and capital resources, and our ability to achieve our key initiatives for 2021. A more detailed description of these and certain other factors that could affect actual results is included in the Company's filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date hereof, except as may be required by law.

    urban-gro Investor Relations Contact:

    Jenene Thomas

    Chief Executive Officer

    JTC Team, LLC

    T: 833.475.8247

    [email protected]

    Media Contact:

    Stan Wagner

    Managing Director

    Maverick Public Relations 

    T: 303.618.5080

    [email protected]



    Primary Logo

    Get the next $CRON alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CRON
    $UGRO

    CompanyDatePrice TargetRatingAnalyst
    Cronos Group Inc.
    $CRON
    11/2/2022$3.00Mkt Perform
    Bernstein
    Cronos Group Inc.
    $CRON
    7/28/2022Hold → Buy
    Canaccord Genuity
    Cronos Group Inc.
    $CRON
    5/11/2022Neutral → Sector Outperform
    CIBC
    Cronos Group Inc.
    $CRON
    3/22/2022Underweight → Equal Weight
    Barclays
    urban-gro Inc.
    $UGRO
    3/21/2022$20.00Buy
    Maxim Group
    Cronos Group Inc.
    $CRON
    3/7/2022$4.00 → $3.00Neutral
    Piper Sandler
    Cronos Group Inc.
    $CRON
    2/22/2022$7.00 → $4.25Sell
    Canaccord Genuity
    Cronos Group Inc.
    $CRON
    2/22/2022$7.00 → $4.00Neutral
    Piper Sandler
    More analyst ratings

    $CRON
    $UGRO
    Financials

    Live finance-specific insights

    See more
    • Cronos Group Inc. to Hold 2025 First Quarter Earnings Conference Call on May 8, 2025

      TORONTO, April 24, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2025 first quarter earnings conference call on Thursday, May 8, 2025 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay on t

      4/24/25 8:00:00 AM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care
    • Cronos Group Inc. to Hold 2024 Fourth Quarter and Full-Year Earnings Conference Call on February 27, 2025

      TORONTO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2024 fourth-quarter and full-year earnings conference call on Thursday, February 27, 2025 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be arch

      2/24/25 4:45:45 PM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care
    • Cronos Group Inc. to Hold 2024 Third Quarter Earnings Conference Call on November 12, 2024

      TORONTO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2024 third quarter earnings conference call on Tuesday, November 12, 2024 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay

      10/29/24 4:15:00 PM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care

    $CRON
    $UGRO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders

      TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2025 Annual Meeting of Shareholders on Friday, June 20, 2025, at 11:00 a.m. ET. Cronos will be conducting the meeting in a virtual-only format via live audio webcast. Registered shareholders and duly appointed proxyholders will have an equal opportunity to participate in the 2025 Annual Meeting online regardless of their geographic location, including a chance to ask questions and vote. The Company's proxy statement describing the formal business to be conducted at the meeting and containing detailed instructions about how to participate in the meeting is avail

      4/28/25 4:00:00 PM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care
    • Cronos Group Inc. to Hold 2025 First Quarter Earnings Conference Call on May 8, 2025

      TORONTO, April 24, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2025 first quarter earnings conference call on Thursday, May 8, 2025 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay on t

      4/24/25 8:00:00 AM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care
    • Cronos Unveils New Spinach® 1.2g Vapes and SOURZ by Spinach® Gummies Enhanced with Rare Cannabinoids

      TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc.'s (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") best-selling cannabis brand, Spinach®, is thrilled to introduce three all-new 1.2g vape products, each expertly crafted with premium THC and enhanced with rare cannabinoids for a uniquely elevated experience. Along with these innovative vape offerings, Cronos is also unveiling new SOURZ by Spinach® Fully Blasted flavors, infused with rare cannabinoids. The new lineup includes three new 1.2 gram vapes in the following formats: Mango Kiwi Haze CBC (Sativa): A refreshing, uplifting blend with a 1:10 CBC-to-THC ratio.Peach Passionfruit Kush CBN (Indica): A dreamy, restful expe

      4/22/25 8:00:00 AM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care

    $CRON
    $UGRO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Doucet Terrence Gregory Joseph converted options into 12,876 shares and covered exercise/tax liability with 6,266 shares, increasing direct ownership by 10% to 70,141 units (SEC Form 4)

      4 - Cronos Group Inc. (0001656472) (Issuer)

      5/13/25 6:36:28 PM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care
    • Officer Weigensberg Arye converted options into 12,132 shares, increasing direct ownership by 10% to 129,469 units (SEC Form 4)

      4 - Cronos Group Inc. (0001656472) (Issuer)

      5/13/25 6:35:37 PM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 4 filed by Officer Buggy Shannon

      4 - Cronos Group Inc. (0001656472) (Issuer)

      5/13/25 6:34:30 PM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care

    $CRON
    $UGRO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by urban-gro Inc. (Amendment)

      SC 13G/A - urban-gro, Inc. (0001706524) (Subject)

      6/10/24 4:48:01 PM ET
      $UGRO
      Industrial Specialties
      Consumer Discretionary
    • SEC Form SC 13D/A filed by Cronos Group Inc. (Amendment)

      SC 13D/A - Cronos Group Inc. (0001656472) (Subject)

      4/25/24 6:39:55 PM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by urban-gro Inc. (Amendment)

      SC 13G/A - urban-gro, Inc. (0001706524) (Subject)

      2/14/24 4:06:57 PM ET
      $UGRO
      Industrial Specialties
      Consumer Discretionary

    $CRON
    $UGRO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Wilks Lewis bought $29,000 worth of shares (20,000 units at $1.45), increasing direct ownership by 12% to 184,108 units (SEC Form 4)

      4 - urban-gro, Inc. (0001706524) (Issuer)

      6/6/24 5:23:34 PM ET
      $UGRO
      Industrial Specialties
      Consumer Discretionary

    $CRON
    $UGRO
    Leadership Updates

    Live Leadership Updates

    See more
    • Cronos Appoints Anna Shlimak as Chief Financial Officer

      TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company"), an innovative global cannabinoid company, today announced the appointment of Anna Shlimak as Chief Financial Officer, effective today. Ms. Shlimak, who previously served as Cronos' Chief Strategy Officer, will succeed James Holm who is stepping down to pursue other opportunities and will remain with the Company through April 18, 2025 to ensure a seamless transition. Ms. Shlimak has been an integral part of Cronos' leadership team for the last seven years, playing a key role in shaping the Company's strategy, operational efficiencies, and engagement with the financial and

      3/19/25 7:30:00 AM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care
    • Cronos Group Inc. Announces Results of Reconvened 2024 Annual Meeting of Shareholders

      TORONTO, July 22, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") announces that at its Annual Meeting of Shareholders (the "Meeting") reconvened July 19, 2024, approximately 98.6% of shareholders voting in person or by proxy approved the appointment of Davidson & Company LLP as the Company's independent auditor for fiscal year 2024 and authorized the Board of Directors of the Company to fix the independent auditor's remuneration. For complete results on all matters voted on at the Meeting, please see the Report of Voting Results filed on the Company's SEDAR+ profile at www.sedarplus.com and the Company's Form 8-K filed on EDGAR at www.sec.g

      7/22/24 4:15:00 PM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care
    • Cronos Group Inc. Announces Results of 2024 Annual Meeting of Shareholders

      TORONTO, June 21, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") announces that at its Annual Meeting of Shareholders held yesterday, June 20, 2024 (the "Meeting"), shareholders holding a total of 274,097,252 common shares of the Company voted in person or by proxy, representing 71.75% of the total number of common shares of the Company outstanding. Each of the directors listed as a nominee in the Company's definitive proxy statement dated April 26, 2024 was elected as a director of the Company, with each director receiving in excess of 93.4% of the votes cast in favor of his or her election. The detailed results of the vote for the electio

      6/21/24 4:30:00 PM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care

    $CRON
    $UGRO
    SEC Filings

    See more
    • SEC Form 10-Q filed by Cronos Group Inc.

      10-Q - Cronos Group Inc. (0001656472) (Filer)

      5/8/25 7:33:20 AM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care
    • Cronos Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

      8-K - Cronos Group Inc. (0001656472) (Filer)

      5/8/25 7:32:08 AM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by urban-gro Inc.

      SCHEDULE 13G/A - urban-gro, Inc. (0001706524) (Subject)

      5/7/25 5:16:50 PM ET
      $UGRO
      Industrial Specialties
      Consumer Discretionary

    $CRON
    $UGRO
    Insider purchases explained

    Analytical look into recent insider purchases

    See more
    • Insider Analysis: Purchase at urban-gro Inc. on Jun 6

      Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

      6/10/24 12:49:49 AM ET
      $UGRO
      Industrial Specialties
      Consumer Discretionary

    $CRON
    $UGRO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Bernstein initiated coverage on Cronos Group with a new price target

      Bernstein initiated coverage of Cronos Group with a rating of Mkt Perform and set a new price target of $3.00

      11/2/22 6:32:18 AM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care
    • Cronos Group upgraded by Canaccord Genuity

      Canaccord Genuity upgraded Cronos Group from Hold to Buy

      7/28/22 9:01:16 AM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care
    • Cronos Group upgraded by CIBC

      CIBC upgraded Cronos Group from Neutral to Sector Outperform

      5/11/22 7:33:42 AM ET
      $CRON
      Medicinal Chemicals and Botanical Products
      Health Care